Clopidogrel & Cerebrovascular
Effect of CYP2C19 polymorphism on risk of TIA, stroke, stent thrombosis, or death in patients with symptomatic intracranial stenosis treated with clopidogrel (Plavix)
In development
Pharmacogenomics of large Populations
Effect of CYP2C19 polymorphism on risk of TIA, stroke, stent thrombosis, or death in patients with symptomatic intracranial stenosis treated with clopidogrel (Plavix)
Investigate the association of the HLA-G polymorphism, rs1063320, directly with asthma susceptibility and in a pharmacogenetic context as an effect modifier of statin effects on asthma related phenotypes, including exacerbations and lung function using a population based cohort of asthmatics with and without statin use.
Finding patients with methotrexate and drug-induced livery injury, using 2xULN and 3xULN as cutoffs.